IPSC‐derived skin organoids have been employed to model systemic scleroderma and to examine the antifibrotic effects of selective estrogen receptor modulators, further illustrating the value of skin organoids in modeling complex diseases and assessing therapeutic candidates [279]. This evidence concerns the gene ESR1 and systemic sclerosis.